Topical 5% tranexamic acid for the treatment of melasma in Asians: A double-blind randomized controlled clinical trial

Journal of Cosmetic and Laser Therapy

Volumn 14, Issue 3, 2012, Pages 150-154

  Ayuthaya, Pinyapat Kanechorn Na ^a   Niumphradit, Nucha ^a   Manosroi, Aranya ^b   Nakakes, Artit ^a  

^a PHRAMONGKUTKLAO HOSPITAL   (Thailand)

^b CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

Acid; Melasma; Tranexamic; Whitening

Indexed keywords

MELANIN; SUNSCREEN; TRANEXAMIC ACID;

ADULT; ARTICLE; ASIAN; CHLOASMA; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ERYTHEMA; FEMALE; HUMAN; MELASMA AREA AND SEVERITY INDEX; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SKIN PIGMENTATION; TREATMENT DURATION;

ADMINISTRATION, CUTANEOUS; ADULT; ANTIFIBRINOLYTIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BLEACHING AGENTS; DOUBLE-BLIND METHOD; ERYTHEMA; FEMALE; HUMANS; MELANOSIS; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TRANEXAMIC ACID;

EID: 84861083026     PISSN: 14764172     EISSN: 14764180     Source Type: Journal    
DOI: 10.3109/14764172.2012.685478     Document Type: Article

References (21)

1. Snell RS. The pigmentary changes occurring in the breast skin during pregnancy following estrogen treatment. J Invest Dermatol. 1964;42:181-186.
2. Perez M, Sanchez JL, Aguilo F. Endocrinologic profi le of patients with idiopathic melasma. J Invest Dermatol. 1983; 81:543-545. (Pubitemid 14202316)
3. Lutti RJ, Fridmanis M, Misrunas AL. Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of melasma. J Clin Endocrinol Metab. 1985;61:28-31. (Pubitemid 15046190)
4. Pathak MA, Fitzpatrick TB, Kraus EW. Usefulness of retinoic acid in the treatment of melasma. J Am Acad Dermatol. 1986;15:894-899. (Pubitemid 17170795)
5. Maeda K, Tomita Y. Mechanism of the inhibitory effect of tranexamic acid on melanogenesis in cultured human melanocytes in the presence of keratinocyte-conditioned medium. J Health Sci. 2007;53:389-396. (Pubitemid 47196239)
6. Matsunaga K. Treatment of melasma: Effi cacy of topical and systemic treatment. Skin Surgery. 1993;2:52-53.
7. Maeda K, Naganuma M. Topical trans-4-aminomethylcyclohexanecarboxylic acid prevents ultraviolet radiation-induced pigmentation. J Photochem Photobiol B. 1998;47:136-141. (Pubitemid 29108040)
8. EndoY, Nishimura S, Miura A. Deep-vein thrombosis induced by tranexamic acid in idiopathic thrombocytopenic purpura [letter]. JAMA. 1988;259:3561-3562.
9. Woo KS, Tse LKK, Woo JLF, Vallance-Owen J. Massive pulmonary thromboembolism after tranexamic acid antifi brinolytic therapy. Br J Clin Pract. 1989;43:465-466 . (Pubitemid 20017351)
10. Taparia M, Cordingley FT, Leahy MF. Pulmonary embolism associated with tranexamic acid in severe acquired haemophilia. Eur J Haematol. 2002;68:307-309.
11. Rydin E, Lundberg PO. Tranexamic acid and intracranial thrombosis [letter]. Lancet. 1976;2:49.
12. Mekontso-Dessap A, Collet JP, Lebrun-Vignes B, SoubriéC, Thomas D, Montalescot G. Acute myocardial infarction after oral tranexamic acid treatment initiation. Int J Cardiol. 2002;83:267-268. (Pubitemid 34564510)
13. Crouch ER Jr, Williams PB, Gray MK, Crouch ER, Chames M. Topical aminocaproic acid in the treatment of traumatic hyphema. Arch Ophthalmol. 1997;115: 1106-1112. (Pubitemid 27387943)
14. De Bonis M, Cavaliere F, Alessandrini F, Lapenna E, Santarelli F, Moscato U, Schiavello R, Possati GF. Topical use of tranexamic acid in coronary artery bypass operations: a doubleblind, prospective, randomized, placebo-controlled study. J Thorac Cardiovasc Surg. 2000;119:575-580. (Pubitemid 30146538)
15. Vessman J, Stromberg S. Determination of tranexamic acid in biological materials by electron capture gas chromatography after direct derivatization in an aqueous medium. Anal Chem. 1977;49:369-373. (Pubitemid 8062067)
16. Lee JH, Park JG, Lim SH, Kim JY, Ahn KY, Kim MY, Park YM. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: A preliminary clinical trial. Dermatol Surg. 2006;32:626.
17. Manosroi A, Podjanasoonthon K, Manosroi J. Stability and release of topical tranexamic acid liposome formulations. J Cosmet Sci. 2002;53:375-386. (Pubitemid 36419086)
18. Manosroi A, Podjanasoonthona K, Manosroi J. Development of novel topical tranexamic acid liposome formulations. Int J Pharm. 2002;235:61-70. (Pubitemid 34185437)
19. Fitzpatrick TB, Arndt KA, el Mofty AM, Pathak MA. Hydroquinone and psoralens in the therapy of hypermelanosis and vitiligo. Arch Dermatol. 1966;93:589-600.
20. Sanchez IL, Vazquez M. A hydroquinone solution in the treatment of melasma. Int J Dermatol. 1982;21:55-58. (Pubitemid 12171818)
21. Angchaisuksiri P, Aryuchai K, Thanasarnaksorn W, Tantibhaedhyangkul V, Phimolsarnti P, Charuwichitratana S, Tanratanakorn S, Atichartakarn V. Fibrinolytic activity, thrombin generation and safety during long-term treatment with tranexamic acid in Thai patients with melasma. Blood. 2001;98(Part 2):3977 .